Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242379 (
lung cancer
)
71,905
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Immunocompetency was assessed before and after the operation in 40 patients with
lung cancer
by skin reaction against tuberculin (PPD) and dinitrochlorobenzene (DNCB), lymphocyte response to PHA, proportion of T-cells, macrophage migration inhibition test (MIT) and the presence of blocking factor. MIT was positive in 27 per cent and blocking factor was positive in 42 per cent. Immune response paralleled the clinical stage of the lesion. In curative resection cases, the immune response rose postoperatively, but declined in non-resectable or recurrent cases. The influence of postoperative radiation therapy, cancer chemotherapy and host mediated agents on the patients was observed. The feasibility of adjuvant specific immunotherapy is discussed.
Jpn J Surg 1978
Dec
PMID:Immunological responsiveness and adjunct immunotherapy in lung cancer. 73 53
This paper describes the characteristic clinical features, mortality and survival rate of 202 patients diagnosed as having asbestosis by the Institute of Occupational Health between 1934 and 1976. One hundred and thirty-three patients were subjected to a clinical reexamination. Major findings included breathlessness in 118 (88.7%), persistent sputum in 95 (71.4%), crepitations in 77 (58.0%) and finger clubbing in 43 (32.3%). Of the 95 patients with persistent sputum, 19 (20.0%) were nonsmokers. Of the 174 men registered as having asbestosis, 56 had died, whereas the expected number of deaths among men of the same age in the Finnish general population was only 23.4. The respective figures for
lung cancer
were 19 observed and 2.1 expected. No excess mortality was found for other malignomas. Among men with asbestosis, the life expectancy was shorter for smokers than for non- and exsmokers.
Scand J Work Environ Health 1978
Dec
PMID:Clinical features, mortality and survival of patients with asbestosis. 73 87
One hundred and fourteen patients with asbestosis, 59% of whom were chronic cigarette smokers, were subjected to a cytological sputum examination which showed: 36 workers (31.6%) with squamous metaplasia, 20 (17.5%) with benigh columnar cell atypia, 5 (4.4%) with benign dysplasia, 2 with suspicious cells for carcinoma, and 1 with anaplastic (microcellular) carcinoma. Clinically and histologically five lung cancers were verified, two of which were cytologically false negatives. All asbestosis patients with
lung cancer
were chronic smokers. Of the 114 asbestosis patients, 49 (43.0%) had ferruginous bodies in their sputum. The workers from an asbestos quarry more frequently had ferruginous bodies in their specimens than the other patients. Radiographically moderate and severe asbestosis cases showed squamous metaplasia more frequently than those with radiographically slight asbestosis. Most of the detected cellular atypias represented reversible alterations of the respiratory epithelium. It is, however, important to screen the sputum of older (greater than 40 years of age) smoking asbestos workers with benign and suspicious cellular atypias regularly because these alterations may represent the first step int he pathway to bronchogenic cancer. The results of this study did not answer the question of whether bronchial cancer of patients with asbestosis is curable if detected early with cytological methods.
Scand J Work Environ Health 1978
Dec
PMID:Sputum cytology of asbestosis patients. 73 89
In a 20-year prospective study on British doctors, smoking habits were ascertained by questionnaire and
lung cancer
incidence was monitored. Among cigarette smokers who started smoking at ages 16-25 and who smoked 40 or less per day, the annual
lung cancer
incidence in the age range 40-79 was:0.273X10(-12). (cigarettes/day+6)2. (age--22.5)4.5. The form of the dependence on dose in this relationship is subject not only to random error but also to serious systematic biases, which are discussed. However, there was certainly some statistically significant (P less than 0.01) upward curvature of the dose-response relationship in the range 0-40 cigarettes/day, which is what might be expected if more that one of the "stages" (in the multistage genesis of bronchial carcinoma) was strongly affected by smoking. If a higher than linear dose-response relationship exists between dose per bronchial cell and age-specific risk per bronchial cell, this may help explain why bronchial carcinomas chiefly arise in the upper bronchi, for dilution effects might then protect the larger areas lower in the bronchial tree.
J Epidemiol Community Health (1978) 1978
Dec
PMID:Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. 74 22
A prospective study designed to detect early
lung cancer
in a high risk outpatient volunteer population is in progress. At present all 10,362 volunteers have been recruited into the project. A review of the radiographs of patients with
lung cancer
identified on the initial screen, or in retrospect, has led to the following conclusions: (1) Independent double reading is important in a screening project. (2) There are no reliable radiographic criteria to distinguish early
lung cancer
from benign disease. (3) The lateral chest radiograph is useful in the high risk patient. From these conclusions the authors have three recommendations for the practicing radiologist. (1) Since double reading improves sensitivity, attempt to doubly read a chest radiograph by removing your eyes from the film and look at it a second time before finalizing your report. (2) Consider any newly appearing, noncalcified lesion in the chest radiograph of a high risk individual as primary
lung cancer
until proven otherwise. (3) Consider the "routine chest radiograph" in a high risk patient as a challenge to detect early
lung cancer
rather than the drudgery of day to day clinical practice.
Radiol Clin North Am 1978
Dec
PMID:Radiographic screening in the early detection of lung cancer. 74 41
This paper provides additional information about the not yet completely solved relation of smoking and
lung cancer
of group Kreyberg II. This problem was analysed for the first time in Austria. In retrospective case-control-study datas were collected about smoking habits of 494 male patients with verivied
lung cancer
(440 cases belonging to group Kreyberg I and 54 to group Kreyberg II) and 1000 controls. By a computer program the relative risk of smokers compared to non smokers, additionaly in relation to the amount of cigarettes smoked, was calculated for: all
lung cancer
types, groups Kreyberg I and Kreyberg II. The relative risk for smokers compared to non smokers was for Kreyberg I-tumours 7.78 and for Kreyberg II-tumours 3.42 (statistically significant). In relation to the amount of cigarettes smoked, Kreyberg I-tumours had a significant risk at an amount up to 5000 consumed cigarette packs, Kreyberg II-tumours at an amount of more than 20000 cigarette packs.
Zentralbl Bakteriol B 1978
Dec
PMID:[Tobacco smoking and lung cancer: relative risk for Kreyberg groups I and II (author's transl)]. 74 24
The effect of radiotherapy on peripheral blood lymphocytes (PBL) of
lung cancer
and the effect of BCG cell-wall skeleton (BCG-CWS) on recovery of impaired PBL were examined. A remarkable depression of the absolute number of E- or EAC-rosette cells and of the response of PBL to mitogens were observed immediately after radiotherapy, and these continued for several months. With BCG-CWS immunotherapy, the response of PBL to phytohemagglutinin recovered rapidly, compared with non-vaccinated patients. The response of PBL to pokeweed mitogen seemed to give similar results. These results suggested that BCG-CWS injection to the patient receiving radiotherapy was effective for recovery of T-cell response.
Gan 1978
Dec
PMID:Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy. 75 Feb 74
Effect of BCG cell-wall skeleton (BCG-CWS) on the recovery of responsiveness of lymphocytes and the survival period was studied in patients with
lung cancer
. (a) Responsiveness of lymphocytes as demonstrated by proliferative response to phytohemagglutinin (PHA) or microcytotoxicity test with cultured cells of a bronchogenic carcinoma was depressed in the patients at later stages of cancer and it was restored by treatment with BCG-CWS in many of such patients. (b) Survival period of the patients at later stages such as III or IV was prolonged by treatment with BCG-CWS. Such an effect was detected even in the patients with carcinomatous pleuritis. (c) A close correlation was found between the reactivity such as PHA response or cytotoxicity and clinical course of the patients given BCG-CWS. Assay system with PHA response and microcytotoxicity test appears to be reliable in anticipating the prognosis and in following clinical course after the BCG-CWS treatment.
Gan 1976
Dec
PMID:Immunotherapy of human lung cancer with BCG cell-wall skeleton. 79 10
Lung cancer
rates in Los Angeles County were reviewed for different occupations and industries. Employment groups found to be at excess risk who have not been previously implicated included roofers, dental lab technicians, decorators, nonautomotive mechanics, photoengravers, clothing ironers, electricians, bar and restaurant managers, janitors: and workers in the radio-TV brooad-casting, dairy, leather, food and drink, bakery, and auto repair industries. Mo
lung cancer
in Los Angeles County had exposure to asbestos, polycyclic aromatic hydrocarbon compounds (PAH), or both.
J Occup Med 1976
Dec
PMID:Occupational differences in rates of lung cancer. 99 73
Based on Texas vital statistics for 1969-71, patterns of
lung cancer
mortality in three ethnic groups are examined. Among males, the risk of
lung cancer
for Mexican Americans is considerably lower than for Blacks and Anglos for ages under 75 and slightly higher for older ages. Among females, Mexican American exhibit a distinct excess of
lung cancer
mortality for ages 70 and over and a deficit for younger ages. The excess among Mexican American females is confined mainly to the older foreign-born women and the excess is reduced for ages 45-60 and diminishes for younger immigrants. This suggests that the excess risk among Mexican Americans will completely disappear within a generation and a general deficit pattern will emerge for all ages. The implications of the diminishing excess and the emerging deficit
lung cancer
mortality among Mexican Americans clearly call for further study in exploring the effect of cultural change on mortality patterns, particularly for cancer.
Cancer 1976
Dec
PMID:Excess and deficit lung cancer mortality in three ethnic groups in Texas. 100 Apr 81
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>